Skip to content

Delavirdine setback in Europe

Chicago: conference summaries

Europe rejects license for delavirdine, delays on amprenavir

Pressure builds for drug price cuts as Durban kicks off

Mass testing programmes necessary for HIV control

Viral load not same guide to AIDS risk in women as in men

Sustiva™ licensed in European Union

International resistance testing guidelines updated

Drug holiday push a result of treating too early, says Cooper